Figure 5.
Radio‐ high‐performance liquid chromatography (HPLC) profiles of plasma after i.v. administration of [14C]‐cilengitide (2.5 mg/kg) to male and female mice (N = 1/gender/time‐point).
Radio‐ high‐performance liquid chromatography (HPLC) profiles of plasma after i.v. administration of [14C]‐cilengitide (2.5 mg/kg) to male and female mice (N = 1/gender/time‐point).